Braskem S.A. (BAK) Stock Price & Analysis
Braskem S.A. (BAK) closed at USD 1.6 on Thursday, October 22, 2026, down 2.44% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 1.64; the Oct 22, 2026 session ranged USD 1.56–1.64 on volume of 1,339,023 shares. Market capitalization is $637.57M, with a 52-week range of USD 1.4–5.4 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BAK.md
Key facts (BAK)
- Analysts: Sell (mean 3.67 on a 1–5 scale) (6 analysts), mean target USD 1.66 (range 1.5–2).
- Total return with dividends: 1Y -39.2% vs S&P 500 +14.9%; 5Y -90.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-12, EPS estimate USD 0.31, revenue estimate $19.3B.
Analysts (BAK)
Consensus Sell (mean 3.67 on a 1–5 scale), 6 analysts; mean target USD 1.66 (low 1.5, high 2).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-28 | HSBC | Downgrade | Buy → Hold | $6.5 → $1.5 |
| 2026-09-16 | UBS | Downgrade | Neutral → Sell | $4 → $1.5 |
| 2026-06-30 | JP Morgan | Downgrade | Overweight → Neutral | |
| 2026-06-26 | Citigroup | Downgrade | Neutral → Sell |
Total return (dividends reinvested) (BAK)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -39.2% | -90.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -39.3% | -37.2% |
| Volatility (annualized) | 81.3% | 59.5% |
| Max drawdown | -71.7% (May 2026→Sep 2026) | -92.4% (Dec 2021→Sep 2026) |
Companies that name BAK in their SEC reports
| Relationship to BAK | Company | Filing | Sentence |
|---|---|---|---|
| partner | PETROBRAS - PETROLEO BRASILEIRO SA (PBR) | 20-F Apr 9, 2026 | “been evaluating the signing of a new Braskem shareholders' agreement with the parties involved, considering ongoing negotiations.” |
| customer | Smartbird, Inc. (BIRD) | 10-K Mar 31, 2026 | “We have a supplier agreement with Braskem S.A., a Brazilian petrochemical company.” |
BAK analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.31 | $0.00 | — | $19.34B | 1 |
| Next quarter (ends Dec 2026) | $-0.46 | $0.00 | — | $18.18B | 1 |
| Current fiscal year (ends Dec 2026) | $0.53 | $2.55 | -79.3% | $75.62B | 2 |
| Next fiscal year (ends Dec 2027) | $-1.08 | $-0.54 | +102.0% | $78.10B | 2 |
Key Statistics (as of October 23, 2026 at 10:11 UTC)
| Price | USD 1.6 |
|---|---|
| Change | ▼ 2.44% (down) |
| Previous Close | USD 1.64 |
| Open | USD 1.63 |
| Day Range | USD 1.56 – 1.64 |
| 52-Week Range | USD 1.4 – 5.4 |
| Volume | 1,339,023 shares |
| Market Cap | $637.57M |
| Exchange | NYQ |
Technical Analysis (BAK)
Nexqual's technical model rates BAK "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.25 (neutral) |
| vs SMA50 | Below (USD 1.77) |
| MACD | -0.03 (negative) |
Analyst Ratings (BAK)
Wall Street analysts rate BAK "Sell" based on 6 analysts, with a mean price target of USD 1.66 (range USD 1.5–2), per Nexqual as of October 23, 2026 at 10:11 UTC.
| Consensus Rating | Sell |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 1.66 |
| High Target | USD 2 |
| Low Target | USD 1.5 |
| Buy / Hold / Sell | 0 / 3 / 3 |
Earnings (BAK)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD 0.31 |
| Revenue Estimate | $19.34B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.62 vs est -3.59 ▲ beat |
| 2025-12-31 | USD -5.33 vs est -1.57 ▼ miss |
| 2025-09-30 | USD 0 vs est -1.18 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financials & Fundamentals (BAK)
| Total Revenue | $70.60B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +21.60% |
| Gross Margin | +11.52% |
| Operating Margin | +17.35% |
| Profit Margin | -7.85% |
| Current Ratio | 0.77 |
| Total Cash | $5.93B |
| Total Debt | $68.30B |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financial Health Score (BAK)
Nexqual rates Braskem S.A.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 10:11 UTC.
| Growth | Weak — Revenue -9% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 12% (last 12 months) |
| Balance Sheet | Mixed — BRL 5.93B cash vs BRL 68.3B debt |
| Cash Flow | Weak — Operating cash flow -BRL 5.80B (TTM) |
| Efficiency | Mixed — No data |
Ownership (BAK)
| Insider Ownership | +0.05% |
|---|---|
| Institutional Ownership | +10.93% |
| Shares Outstanding | 172.53M |
| Float | 44.55M |
| Short % of Float | +5.96% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Leadership (BAK)
Braskem S.A. is led by Helcio Tokeshi, Chief Executive Officer, per Nexqual as of October 23, 2026 at 10:11 UTC.
| Chief Executive Officer | Helcio Tokeshi |
|---|---|
| Investor Relations Officer & CFO | Carlos Augusto Machado Pereira de Almeida Brandão |
| Chief Operating Officer | Raphael Franco de Campos |
| Vice President of People, Communication & Supply Chain | Nir Lander |
Major Backers & Investors (BAK)
Notable institutional backers of Braskem S.A. include 140 Summer Partners LP, Marshall Wace LLP, Barclays Plc, according to Nexqual as of October 23, 2026 at 10:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| 140 Summer Partners LP | 4.65% |
| Marshall Wace LLP | 1.17% |
| Barclays Plc | 0.88% |
| Point72 Asset Management, L.P. | 0.71% |
| LPL Financial LLC | 0.48% |
| Jane Street Group, LLC | 0.47% |
| UBS Group AG | 0.44% |
| X-Square Capital, LLC | 0.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.28% |
| State Street | 0.18% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LXU | LSB Industries, Inc. | USD 9.76 | ▼ 5.33% |
| WLKP | Westlake Chemical Partners LP | USD 20.96 | ▲ 0.43% |
| TROX | Tronox Holdings plc | USD 3.48 | ▲ 6.75% |
| RYAM | Rayonier Advanced Materials Inc | USD 6.83 | ▼ 2.29% |
| GPRE | Green Plains, Inc. | USD 13.91 | ▼ 1.77% |
| ASIX | AdvanSix Inc. | USD 15.68 | ▲ 1.55% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt